The "Self-Reliance" Mandate and Supply Chain Resilience in China's Biotech Sector
National security and pharmaceutical production have become inseparable in the post-pandemic era. In 2026, the China Biopharmaceuticals Market is being reshaped by the government's "Self-Reliance" mandate, which treats the biological supply chain as a pillar of national stability. Under the latest iteration of the Five-Year Plan, China is making "Decisive Breakthroughs" in critical upstream...
0 Комментарии 0 Поделились 67 Просмотры 0 предпросмотр
Спонсоры